Role of CYP2C19 pharmacogenetic polymorphism on response of esomeprazole in the treatment of GERD

被引：0
作者：
Halimi, Shafarul
Abu Hassan, Muhammad Radzi
Ismail, Rusli
Kiew, Kuang Kiat
Zainuddin, Zalwani
Mustapha, Mohd Nazri
Mokhtar, Suraya
机构：
[1] Univ Sains Malaysia, George Town, Malaysia
[2] Hosp Univ Sains Malaysia, George Town, Malaysia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
pharmacogenetics; polymorphism; GERD;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [1] The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19
    Yang, Yao
    Lewis, Joshua P.
    Hulot, Jean-Sebastien
    Scott, Stuart A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (10) : 1599 - 1617
  • [2] Optimal dose regimens of esomeprazole for gastric acid suppression with minimal influence of the CYP2C19 polymorphism
    Lou, Horng-Yuan
    Chang, Chun-Chao
    Sheu, Ming-Thau
    Chen, Ying-Chen
    Ho, Hsiu-O
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (01) : 55 - 64
  • [3] Optimal dose regimens of esomeprazole for gastric acid suppression with minimal influence of the CYP2C19 polymorphism
    Horng-Yuan Lou
    Chun-Chao Chang
    Ming-Thau Sheu
    Ying-Chen Chen
    Hsiu-O Ho
    European Journal of Clinical Pharmacology, 2009, 65
  • [4] The CYP2C19 enzyme polymorphism
    Wedlund, PJ
    PHARMACOLOGY, 2000, 61 (03) : 174 - 183
  • [5] CYP2C19 genetic polymorphism in the Vietnamese population
    Nhung Phuong Vu
    Hoa Thi Thanh Nguyen
    Ngoc Thi Bich Tran
    Ton Dang Nguyen
    Hue Thi Thu Huynh
    Xuan Thi Nguyen
    Duong Thuy Nguyen
    Hai Van Nong
    Ha Hai Nguyen
    ANNALS OF HUMAN BIOLOGY, 2019, 46 (06) : 491 - 497
  • [6] CYP2C19 gene polymorphism in Ningxia
    Yang, Zhen
    Xie, Yunqian
    Zhang, Daya
    Zou, Yan
    Li, Ximei
    Chen, Runxiang
    Zhang, Xiaodong
    Chen, Shiju
    Bai, Feihu
    PHARMACOLOGICAL REPORTS, 2023, 75 (03) : 705 - 714
  • [7] CYP2C19 gene polymorphism in Ningxia
    Zhen Yang
    Yunqian Xie
    Daya Zhang
    Yan Zou
    Ximei Li
    Runxiang Chen
    Xiaodong Zhang
    Shiju Chen
    Feihu Bai
    Pharmacological Reports, 2023, 75 : 705 - 714
  • [8] The role of CYP2C19 polymorphism in the development of adverse effects to drugs and the risk for diseases
    Alonso-Navarro, Hortensia
    Jimenez-Jimenez, Felix J.
    Garcia-Agundez, Jose A.
    MEDICINA CLINICA, 2006, 126 (18): : 697 - 706
  • [9] Genetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole
    Zalloum, Imad
    Hakooz, Nancy
    Arafat, Tawfiq
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (04) : 4195 - 4200
  • [10] Genetic polymorphism of CYP2C19 & therapeutic response to proton pump inhibitors
    Chaudhry, A. S.
    Kochhar, R.
    Kohli, K. K.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2008, 127 (06) : 521 - 530
12345